Reviewed by RC Nelson, health and wellness writer. Last updated July 2026. Embody’s public pricing pages and published terms were reviewed on September 22, 2026; see Pricing below.
Quick Answer
Embody at a glance:
- Pricing: Embody’s site advertises GLP-1 injections from “$79/month” and GLP-1/GIP injections from “$129/month”. Separately, its published terms set out two programmes with their own rates. We could not establish which applies at checkout
- Visit type: async only, no video required
- Insurance: cash-pay, HSA/FSA accepted
- Included: a personalized metabolic report, 1:1 specialist guidance, and care that Embody says is provided through OpenLoop Health
- Best for: first-time GLP-1 users who want a low entry price and a metabolic baseline
- Watch out for: this is a recurring subscription. Embody’s terms state that payments are final and that cancellation must reach them at least 72 hours before the next billing date
See our Embody provider profile or compare every vetted telehealth provider.
Key Takeaways
- Embody’s site advertises GLP-1 injections from $79/mo and GLP-1/GIP injections from $129/mo, listed by drug class rather than by molecule
- Its published terms list prices by molecule under two programmes, Start and Flat, which Embody states may not be combined. Neither table contains $79 or $129
- We could not establish which of these applies at checkout, so treat every figure in this review as a quotation from a source, not as a quote for you
- Embody’s FAQ separately states that your price does not increase if your dose changes within the same medication, and that pricing varies by the plan length you select
- Every plan includes a personalized metabolic report and 1:1 specialist guidance
- Embody’s site states that medical treatment is provided by OpenLoop Health, which it describes as an affiliated network of medical professional corporations and associations
- HSA/FSA cards are accepted. Embody does not bill insurance
- Compounded semaglutide and tirzepatide only, and compounded drugs are not FDA-approved as finished products
- Embody’s terms say the service is offered in “certain states”, and Embody asks readers to contact support for current state availability
I’ve been tracking compounded GLP-1 pricing for about a year, and Embody’s advertised $79 is among the lowest headline figures I have seen. That is below GobyMeds, which has held the budget crown at $99 for a while. So is Embody actually the cheapest way to start? I could not answer that from Embody’s published material. The price on its homepage and the prices in its terms do not match, and nothing I could find states which one you are offered at checkout. Here is what each source says, and what to ask before you commit.
What Is Embody
Embody is a telehealth platform that prescribes compounded GLP-1 medications for weight loss. You fill out an intake, a licensed clinician reviews it, and if you are approved, your medication ships to your door. No video visit, no pharmacy runs.
Two things make it worth a closer look. The first is that low advertised price. The second is what comes bundled with it: a personalized metabolic report that gives you a baseline before you start, plus 1:1 specialist guidance and 24/7 access to the care team. Embody’s site states that medical treatment is provided by OpenLoop Health, which it describes as an affiliated network of medical professional corporations and associations.
Pricing, and What We Could Not Confirm
Embody publishes pricing in two places that do not agree, and this review does not resolve them.
What the site advertises. As of September 22, 2026 Embody’s homepage lists two products with a “starting at” price: GLP-1 Injections at $79/month and GLP-1 / GIP Injections at $129/month. It does not name the molecule at either price, and it does not state what the price becomes after the first billing period.
What the published terms say. Embody’s Terms and Conditions contain a “Program Options & Pricing” section setting out two programmes that it states are separate and may not be combined:
- Start Program, which Embody describes as “a reduced first-month price followed by standard monthly pricing beginning in month two.” Its table lists Semaglutide Injection at $99 for month 1 and $299/month from month 2; Semaglutide Gum $149 then $349; Tirzepatide Injection $149 then $399; Tirzepatide Gum $199 then $449.
- Flat Program, which Embody describes as “fixed monthly pricing that does not increase over time, with optional commitment-based discounts.” It lists Semaglutide Injection at $199/month, $169/month on a 3-month bundle, $159/month on 6 months and $149/month on 12 months, with stated adjustments of +$50/month for Semaglutide Gum, +$100/month for Tirzepatide Injection and +$50/month for Tirzepatide Gum.
Why these are not one claim. Neither $79 nor $129 appears anywhere in the published tables, and the tables are organised by molecule while the homepage is organised by drug class. I could not determine whether the advertised figures are an entry point into one of these programmes, a separate offer, or a rate quoted only at checkout. This review therefore does not attach any renewal price to the advertised figures.
A separate statement about dose. Embody’s FAQ says your price “does not increase if your dose changes within the same medication” and that pricing “varies only by the treatment plan you select (4-, 12-, 24-, or 52-week plans), as shown during checkout.” That is a statement about changing dose within a medication. It is not a statement that no price rises over time, and it sits alongside a Start Program whose own description increases in month two. Both statements are Embody’s, and this review presents them separately rather than merging them.
None of the figures above is a quote for your situation, and the terms are not confirmation of what you will be offered. Embody says the plan is shown at checkout, so that is where to read your own number.
For context only, here is how the advertised headline figure sits against other providers’ published entry prices:
| Provider | Starting price | Medication |
|---|---|---|
| Embody | $79/mo advertised “starting at” (its published terms list different figures — see above) | Compounded semaglutide, tirzepatide |
| GobyMeds | $99/mo (steady) | Compounded semaglutide |
| Henry Meds | $149/mo | Compounded semaglutide, tirzepatide |
| Hims | $199/mo | Brand-name semaglutide (Wegovy) |
On the advertised figure alone, Embody’s $79 is the lowest in that table. That comparison is weaker than it looks. GobyMeds’ $99 is a standard rate, whereas the lowest non-bundled monthly figure in Embody’s own published tables is $199/month for semaglutide injection, with $149/month appearing only on a 12-month commitment. Because I could not establish which Embody price applies at checkout, I am not ranking the two on annual cost. If a price you can verify in advance matters to you, note that Embody’s terms describe the Flat Program as fixed and the Start Program as increasing in month two, and that its multi-month bundles are non-refundable in whole or in part.
What You Actually Get
The metabolic report is the part I would not skip past. Most budget providers hand you medication and a portal login. Embody gives you a baseline read on your metabolism before treatment starts, which is useful context when you are deciding whether the scale is moving because of the drug, your habits, or both.
HSA and FSA cards are accepted, which matters more than it sounds. An advertised $79 paid with pre-tax dollars is effectively cheaper still, and it is one of the few line items in GLP-1 shopping where you can legitimately trim the cost without switching providers. Embody does not bill insurance directly, so if your plan already covers brand-name Wegovy or Zepbound, going through insurance may still beat any cash-pay program, Embody included. Check that first.
Medications
Embody prescribes compounded semaglutide and compounded tirzepatide, both as injections. Semaglutide is the active ingredient in Ozempic and Wegovy. Tirzepatide is the dual-action ingredient in Mounjaro and Zepbound. Both are compounded by a pharmacy rather than produced by a brand manufacturer.
One thing to be clear about: compounded medications are not FDA-approved as finished products. They use FDA-approved active ingredients, but the compounded version itself has not gone through the FDA's finished-drug review. If you specifically want brand-name Wegovy or Zepbound, Embody is not your platform. Look at Ro or Eden for brand-name access.
On trust signals, Embody’s site displays a LegitScript seal linking to LegitScript’s verification page for its domain. I confirmed the seal and the link are present on Embody’s site, but I could not retrieve a certification status from LegitScript itself, because that lookup sits behind a challenge form. Follow the seal link and read the status yourself before you sign up, the same way you would for any cash-pay telehealth brand.
How It Works
- Complete an online health questionnaire. Weight, medical history, current medications, goals. Standard intake.
- A clinician reviews it. Embody says this is handled through the OpenLoop Health network. Async, so no scheduled video call.
- Medication ships with your plan. You get the medication, a personalized plan, and your metabolic report at your door. Shipping is free.
- Ongoing support. 1:1 guidance and 24/7 access to the care team for as long as you are on the program.
The Pros
The advertised headline price is low. At $79/month, Embody’s advertised figure is among the lowest published in the compounded category. Read it alongside the Pricing section above, because its own terms list different figures.
HSA/FSA accepted. A rare place to shave cost with pre-tax dollars.
The metabolic report adds context. A baseline most budget providers skip.
The Cons
The published pricing does not reconcile. Embody advertises $79/month, and its Terms and Conditions list different figures under two named programmes. I could not determine which you are offered. Confirm your number at checkout before you commit.
Compounded only. No brand-name Wegovy, Ozempic, or Zepbound.
Newer platform. Embody does not have the track record of a Hims or a Ro. Not a red flag on its own, but worth weighing.
Who Embody Is Best For
Embody makes the most sense for a first-time GLP-1 user who wants to start cheap and see a metabolic baseline before committing to a maintenance-dose budget. The advertised $79 plus HSA/FSA eligibility is one of the lowest published on-ramps in the compounded market — but confirm at checkout which programme you are entering.
It is a weaker fit if you already know you will be on a higher dose long term, or if you want a price you can verify before you start. Embody’s terms describe a Flat Program that does not increase and a Start Program that rises in month two, and I could not tell which the advertised figure belongs to. A steady $99 at GobyMeds, or a same-price-at-every-dose model like Eden’s, is easier to budget against even though the headline number is higher.
The Bottom Line
Embody’s pitch is price. Seventy-nine dollars advertised to start, $129 for the GLP-1/GIP option, a metabolic report in the box, and HSA/FSA accepted. What I cannot tell you from Embody’s published material is what you pay in month two, because its advertised figures and its published programme tables do not match.
So read the word “starting” carefully. Embody’s terms describe one programme that increases after the first month and one that does not, its FAQ says a dose change does not move your price, and none of those statements is attached to the $79 on its homepage. It is a recurring subscription, Embody states payments are final, and cancellation must reach them at least 72 hours before your next billing date. Get your plan and your renewal price in writing at checkout.
GLP1 Clinics has no direct affiliate relationship with Embody. Embody ended its affiliate programme in July 2026 and we hold no active tracking link for it; verified September 22, 2026. Links to Embody go to its own website.
Ready to compare your options? Compare active providers.
Frequently Asked Questions
How much does Embody cost? Embody’s site advertises GLP-1 injections from $79 per month and GLP-1/GIP injections from $129 per month. Separately, its Terms and Conditions list a Start Program (Semaglutide Injection $99 for month 1, $299/month from month 2; Tirzepatide Injection $149 then $399) and a Flat Program (Semaglutide Injection $199/month, falling to $149/month on a 12-month bundle). The advertised figures do not appear in those tables, and we could not establish which applies at checkout. Sources reviewed September 22, 2026.
What medications does Embody offer? Embody offers compounded semaglutide and compounded tirzepatide, both as injections. Both are pharmacy-compounded versions of the active ingredients in brand-name GLP-1 medications, and compounded drugs are not FDA-approved as finished products.
Does Embody accept insurance or HSA/FSA? Embody is cash-pay and does not bill insurance, but HSA and FSA cards are accepted. If your insurance already covers a brand-name GLP-1, going through your plan may cost less than any cash-pay program.
Is Embody legit? Embody’s site displays a LegitScript seal that links to LegitScript’s verification page for its domain. We could not retrieve a certification status from LegitScript directly, because that lookup is behind a challenge form, so follow the seal link and check it yourself. Embody’s site also states that medical treatment is provided by OpenLoop Health, which it describes as “an affiliated network of medical professional corporations and associations”. That is Embody’s description of its own arrangement; we did not verify any individual clinician’s credentials. Compounded medications are not FDA-approved as finished products.
Is Embody available in my state? Embody’s terms state that its services “are currently available to individuals located in certain states”, and Embody asks readers to contact support for current state availability. Its eligibility terms also require you to be 18 or older and living in the United States. Confirm availability for your own state with Embody before you start. (Terms reviewed September 22, 2026.)
How does Embody compare to Hims and GobyMeds? Advertised starting prices are not directly comparable across providers. A headline figure only means something once you match the medication and dose it covers, the commitment length it assumes, the services included in it, and what the price becomes at renewal. Embody publishes a “starting at” figure on its site and separate programme tables in its terms, and we could not establish which applies at checkout, so this review does not rank Embody against other providers on price.